Brief: Ampio Pharmaceuticals Says Michael Martino To Become Interim Chairman And CEO
22/11/2021 17:12
Nov 22 (Reuters) - Ampio Pharmaceuticals Inc AMPE.A :
* BOARD MEMBER MICHAEL MARTINO TO BECOME INTERIM CHAIRMAN
AND CEO
OF AMPIO PHARMACEUTICALS, MIKE MACALUSO TO TAKE MEDICAL LEAVE
* AMPIO PHARMACEUTICALS INC - ANNOUNCEMENT FOLLOWS
MACALUSO'S
DISCLOSURE IN OCTOBER, 2021, THAT HE WAS UNDERGOING MEDICAL
TREATMENT
Source text for Eikon: ID:nPn5nmf4na
Further company coverage: AMPE.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank